Home > Healthcare > Pharmaceuticals > Finished Drug Form > Pregnancy Medication Market

Pregnancy Medication Market Size

Report ID: GMI5385
Published Date: Oct 2022
Report Format: PDF

Download Free Sample

Pregnancy Medication Market Size

Pregnancy Medication Market size was valued at over USD 33 billion in 2022 and is poised to witness 13% CAGR from 2023 to 2032.

Rapid development in incidences of pregnancy-associated complications is expected to drive the demand for pregnancy medication. Based on estimates by the World Health Organization, every day, almost 800 women worldwide die due to complications during childbirth. These intricacies are 36 times more prevalent in developing economies than in developed countries. The alarming progress in childbirth-related complications can be attributed to improper dietary habits, physical inactivity, and the rising adoption of a sedentary lifestyle.

To get key market trends

Download Free Sample

Consumption of unhealthy food during pregnancy can increase the risk of developing various long-term irreversible health issues. These may range from high blood pressure, cholesterol, heart diseases, and type 2 diabetes to defective childbirth. The rapid inclination toward maintaining a proper nutritional diet rich in all micro and macronutrients to support the health of the mother and the fetus will create positive growth prospects for the pregnancy medication industry.

Pregnancy Medication Market Report Attributes
Report Attribute	Details
Base Year:	2022
Pregnancy Medication Market Size in 2022:	33 Billion (USD)
Forecast Period:	2023 to 2032
Forecast Period 2023 to 2032 CAGR:	13%
2032 Value Projection:	112 Billion (USD)
Historical Data for:	2017 to 2022
No. of Pages:	255
Tables, Charts & Figures:	261
Segments covered:	Drug Class, Pregnancy Stage, Distribution Channel, and Region
Growth Drivers:	Growing incidence of complications during pregnancy Significant benefits of dietary supplements in pregnancy Rising awareness regarding pregnancy care
Pitfalls & Challenges:	Side effects and risks associated with the use of other medication Declining birth rate across the world

Learn more about the key segments shaping this market

Download Free Sample

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Global market size for pregnancy medication exceeded USD 33 billion in 2022 and is projected to exhibit around 13% CAGR from 2023 to 2032 owing to the surging incidences of complexities associated with pregnancy and childbirth.

Nutritional supplements segment was worth over USD 16.5 billion in 2022 and is anticipated to amass significant market share by 2032 due to the proven benefits of nutritional supplements in supporting healthy fetal growth and preventing the prospects of neural tube defects.

Retail pharmacy segment is predicted to hold around 28% market share by 2032, driven by the availability of a wide range of health products and customized prescription and treatment at affordable prices.

Notable players in the pregnancy medication MARKET are Alkem Laboratories Limited, Piramal Enterprises Limited, F.Hoffman-La Roche Ltd, Pfizer, Dr. Reddy’s Laboratories, Cipla Inc, Alembic Pharmaceuticals Ltd, Lupin Limited, Glenmark Pharmaceuticals Ltd, Viatris Inc., (Mylan Inc.), Amgen Inc., and others.